Cart
sales@molnova.com
Lirequinil
CAS No. 143943-73-1
Lirequinil( —— )
Catalog No. M34317 CAS No. 143943-73-1
Lirequinil (Ro 41-3696) is a small molecule GABAA receptor agonist utilized in the study of neurological disorders.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 380 | In Stock |
|
| 10MG | 570 | In Stock |
|
| 25MG | 911 | In Stock |
|
| 50MG | 1190 | In Stock |
|
| 100MG | 1628 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 3246 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLirequinil
-
NoteResearch use only, not for human use.
-
Brief DescriptionLirequinil (Ro 41-3696) is a small molecule GABAA receptor agonist utilized in the study of neurological disorders.
-
DescriptionLirequinil (Ro 41-3696) is an orally active partial agonist of the benzodiazepine (BDZ) receptor. Lirequinil has the effect of promoting sleep.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorGABA Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number143943-73-1
-
Formula Weight448.94
-
Molecular FormulaC26H25ClN2O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(=O)(C1=C2C=3C(CCN2C(=O)C(=C1)C4=CC=CC=C4)=CC=C(Cl)C3)N5C[C@@H](OCC)CC5
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. M Tsuboi, et al. Changes in mouse hippocampal EEG characteristics after oral administration of Ro 41-3696, nitrazepam, or zopiclone alone and in combination with ethanol. Pharmacology. 1994 Nov;49(5):278-85. ?
molnova catalog
related products
-
Propiosyringone
Propiosyringone is from the degradation of Eucalyptus globulus wood by wood-rotting fungi.
-
Scopine HCl
Scopine HCl salt is the metabolite of anisodine, which is a α1-adrenergic receptor agonist and used in the treatment of acute circulatory shock.
-
Nicotredole
Nicotredole (Tryptamide) is an orally active anti-inflammatory and analgesic agent. Nicotredole exhibits evident antiinflammatory effects of potency comparable with Phenylbutazone. Nicotredole has only weak ulcerogenic activity.
